Liposomal antineoplastic drugs and uses thereof
US7244448B2 · kind B2 · utility
13Cited by
7References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 29, 2001 |
| Grant date | Jul 17, 2007 |
| Priority date | — |
| Expiry date | Jun 29, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to liposomal antineoplastic agents (e.g., camptothecin) compositions and methods of using such compositions for treating neoplasia and for inhibiting angiogenesis. The compositions and methods are useful for modulating the plasma circulation half-life of an active agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.